These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 211933)

  • 21. Specific binding of [3H]kainic acid to receptor sites in rat brain.
    London ED; Coyle JT
    Mol Pharmacol; 1979 May; 15(3):492-505. PubMed ID: 492142
    [No Abstract]   [Full Text] [Related]  

  • 22. Strain differences and kainic acid neurotoxicity.
    Sanberg PR; Pisa M; McGeer EG
    Brain Res; 1979 Apr; 166(2):431-5. PubMed ID: 427597
    [No Abstract]   [Full Text] [Related]  

  • 23. Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease.
    Coyle JT; Ferkany JW; Zaczek R
    Neurobehav Toxicol Teratol; 1983; 5(6):617-24. PubMed ID: 6142425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethanol, baclofen, and kainic acid neurotoxicity.
    McGeer EG; Jakubovic A; Singh EA
    Exp Neurol; 1980 Aug; 69(2):359-64. PubMed ID: 7409049
    [No Abstract]   [Full Text] [Related]  

  • 25. Structure-activity relations for the neurotoxicity of kainic acid derivatives and glutamate analogues.
    Schwarcz R; Scholz D; Coyle JT
    Neuropharmacology; 1978 Feb; 17(2):145-51. PubMed ID: 634450
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
    Zharkovskiĭ AM; Nurk AM
    Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diminished decarboxylation of L-DOPA in rat striatum after intrastriatal injections of kainic acid.
    Melamed E; Hefti F; Wurtman RJ
    Neuropharmacology; 1980 Apr; 19(4):409-11. PubMed ID: 7383284
    [No Abstract]   [Full Text] [Related]  

  • 28. Reduced GABA transaminase activity in the Huntington's disease putamen.
    Carter CJ
    Neurosci Lett; 1984 Aug; 48(3):339-42. PubMed ID: 6237280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonergic denervation partially protects rat striatum from kainic acid toxicity.
    Berger M; Sperk G; Hornykiewicz O
    Nature; 1982 Sep; 299(5880):254-6. PubMed ID: 6213866
    [No Abstract]   [Full Text] [Related]  

  • 30. Morphine, naloxone and kainic acid neurotoxicity.
    McGeer EG; McGeer PL; Vincent SR
    Res Commun Chem Pathol Pharmacol; 1979 Aug; 25(2):411-4. PubMed ID: 493724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of cortical ablation on the neurotoxicity and receptor binding of kainic acid in striatum.
    Biziere K; Coyle JT
    J Neurosci Res; 1979; 4(5-6):383-98. PubMed ID: 42811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of 2-dimethylaminoethanol in kainate-lesioned rat striatum: anomaly in the radioenzymatic assay of acetylcholine.
    London ED; Harris LW; Heyl WC; Coyle JT
    Commun Psychopharmacol; 1978; 2(4):357-64. PubMed ID: 153218
    [No Abstract]   [Full Text] [Related]  

  • 33. Regional brain atrophy and reductions in glutamate release and uptake after intrastriatal kainic acid.
    Friedle NM; Kelly PH; Moore KE
    Br J Pharmacol; 1978 May; 63(1):151-8. PubMed ID: 148306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
    Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Huntington's disease and its animal model: alterations in kainic acid binding.
    Beaumont K; Maurin Y; Reisine TD; Fields JZ; Spokes E; Bird ED; Yamamura HI
    Life Sci; 1979 Feb; 24(9):809-16. PubMed ID: 156298
    [No Abstract]   [Full Text] [Related]  

  • 36. Protein and RNA synthesis in kainic acid-injected striata.
    Jakubovic A; Lin D; McGeer EG
    Brain Res; 1979 Mar; 163(2):289-94. PubMed ID: 427546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rats chronically injected with urine from Huntington's chorea patients do not striatal damage.
    Perry TL; Hansen S; Kish SJ; MacLean J; Berry K
    Life Sci; 1981 Jun; 28(25):2869-74. PubMed ID: 6455580
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of intrastriatal kainic acid injection on [3H]dopamine metabolism in rat striatal slices: evidence for postsynaptic glial cell metabolism by both the type A and B forms of monoamine oxidase.
    Schoepp DD; Azzaro AJ
    J Neurochem; 1983 May; 40(5):1340-8. PubMed ID: 6131940
    [No Abstract]   [Full Text] [Related]  

  • 39. Some factors influencing the neurotoxicity of intrastriatal injections of kainic acid.
    McGeer EG; McGeer PL
    Neurochem Res; 1978 Aug; 3(4):501-17. PubMed ID: 34114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of intrahippocampal kainic acid injections and surgical lesions on neurotransmitters in hippocampus and septum.
    Fonnum F; Walaas I
    J Neurochem; 1978 Nov; 31(5):1173-81. PubMed ID: 29947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.